10967/276 - QDB Compounds

QsarDB Repository

Zukic, S.; Ivanova, L.; Zusinaite, E.; Merits, A.; Maran, U. Discovery of a Novel Phthalazine-Based VEGFR-2 Inhibitor by Machine Learning Analysis of Diverse Chemical Space with Favorable Pharmacophores and Its Evaluation in Glioblastoma Cell Lines. Results in Chemistry, Under revision

Compound

ID:135
Name:Compound 135
Description:Original numeration in publication: 19
Labels:Training_set, Thiazolidine‐2, 4‐dione
CAS:
InChi Code:InChI=1S/C17H11Cl2N3O3S/c18-11-5-4-10(12(19)8-11)7-13-16(24)22(17(25)26-13)9-15(23)21-14-3-1-2-6-20-14/h1-8H,9H2,(H,20,21,23)/b13-7-

Properties

pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]

ValueSource or prediction
6.24

El-Adl, K.; Sakr, H.; El-Hddad, S. S. A. a. E.-H., A.-G. A.; Nasser, M.; Abulkhair, H. S. Design, synthesis, docking, ADMET profile, and anticancer evaluations of novel thiazolidine-2,4-dione derivatives as VEGFR-2 inhibitors. Arch. Pharm. (Weinheim) 2021, 354, e2000491. https://doi.org/10.1002/ardp.202000491

6.20073

Eq1: VEGFR-2 inhibition (Data used to train model)